Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Inhibition of HDAC8 and HDAC9 by microbial short-chain fatty acids breaks immune tolerance of the epidermis to TLR ligands.

Sanford JA, Zhang LJ, Williams MR, Gangoiti JA, Huang CM, Gallo RL.

Sci Immunol. 2016 Oct 28;1(4). pii: eaah4609. doi: 10.1126/sciimmunol.aah4609.

PMID:
28783689
2.

The mPEG-PCL Copolymer for Selective Fermentation of Staphylococcus lugdunensis Against Candida parapsilosis in the Human Microbiome.

Kao MS, Wang Y, Marito S, Huang S, Lin WZ, Gangoiti JA, Barshop BA, Hyun C, Lee WR, Sanford JA, Gallo RL, Ran Y, Chen WT, Huang CJ, Hsieh MF, Huang CM.

J Microb Biochem Technol. 2016 Aug;8(4):259-265. doi: 10.4172/1948-5948.1000295. Epub 2016 Jun 19.

3.

Hereditary Orotic Aciduria and the Excretion of Orotidine.

Nyhan WL, Gangoiti JA.

Neuropediatrics. 2016 Dec;47(6):408-409. Epub 2016 Aug 30.

PMID:
27574833
4.

Diagnosis and Monitoring of Cystinosis Using Immunomagnetically Purified Granulocytes.

Gertsman I, Johnson WS, Nishikawa C, Gangoiti JA, Holmes B, Barshop BA.

Clin Chem. 2016 May;62(5):766-72. doi: 10.1373/clinchem.2015.252494. Epub 2016 Mar 15.

5.

Perturbations of tyrosine metabolism promote the indolepyruvate pathway via tryptophan in host and microbiome.

Gertsman I, Gangoiti JA, Nyhan WL, Barshop BA.

Mol Genet Metab. 2015 Mar;114(3):431-7. doi: 10.1016/j.ymgme.2015.01.005. Epub 2015 Jan 29.

PMID:
25680927
6.

Metabolic Effects of Increasing Doses of Nitisinone in the Treatment of Alkaptonuria.

Gertsman I, Barshop BA, Panyard-Davis J, Gangoiti JA, Nyhan WL.

JIMD Rep. 2015;24:13-20. doi: 10.1007/8904_2014_403. Epub 2015 Feb 10.

8.

A model-driven quantitative metabolomics analysis of aerobic and anaerobic metabolism in E. coli K-12 MG1655 that is biochemically and thermodynamically consistent.

McCloskey D, Gangoiti JA, King ZA, Naviaux RK, Barshop BA, Palsson BO, Feist AM.

Biotechnol Bioeng. 2014 Apr;111(4):803-15. doi: 10.1002/bit.25133. Epub 2013 Nov 19.

PMID:
24249002
9.

Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD.

Okamura DM, Bahrami NM, Ren S, Pasichnyk K, Williams JM, Gangoiti JA, Lopez-Guisa JM, Yamaguchi I, Barshop BA, Duffield JS, Eddy AA.

J Am Soc Nephrol. 2014 Jan;25(1):43-54. doi: 10.1681/ASN.2012090962. Epub 2013 Sep 5.

10.

Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.

Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, Pu M, Sharma S, You YH, Wang L, Diamond-Stanic M, Lindenmeyer MT, Forsblom C, Wu W, Ix JH, Ideker T, Kopp JB, Nigam SK, Cohen CD, Groop PH, Barshop BA, Natarajan L, Nyhan WL, Naviaux RK.

J Am Soc Nephrol. 2013 Nov;24(11):1901-12. doi: 10.1681/ASN.2013020126. Epub 2013 Oct 10.

11.

Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery.

Dohil R, Cabrera BL, Gangoiti JA, Barshop BA, Rioux P.

Fundam Clin Pharmacol. 2014 Apr;28(2):136-43. doi: 10.1111/fcp.12009. Epub 2012 Oct 31.

PMID:
23113697
12.

The role of DMQ(9) in the long-lived mutant clk-1.

Yang YY, Vasta V, Hahn S, Gangoiti JA, Opheim E, Sedensky MM, Morgan PG.

Mech Ageing Dev. 2011 Jun-Jul;132(6-7):331-9. doi: 10.1016/j.mad.2011.06.009. Epub 2011 Jul 1.

13.

Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study.

Gangoiti JA, Fidler M, Cabrera BL, Schneider JA, Barshop BA, Dohil R.

Br J Clin Pharmacol. 2010 Sep;70(3):376-82. doi: 10.1111/j.1365-2125.2010.03721.x.

14.

Long-term treatment of cystinosis in children with twice-daily cysteamine.

Dohil R, Gangoiti JA, Cabrera BL, Fidler M, Schneider JA, Barshop BA.

J Pediatr. 2010 May;156(5):823-7. doi: 10.1016/j.jpeds.2009.11.059. Epub 2010 Feb 6.

PMID:
20138296
15.

Twice-daily cysteamine bitartrate therapy for children with cystinosis.

Dohil R, Fidler M, Gangoiti JA, Kaskel F, Schneider JA, Barshop BA.

J Pediatr. 2010 Jan;156(1):71-75.e1-3. doi: 10.1016/j.jpeds.2009.07.016.

PMID:
19775699
16.

The effect of different ubiquinones on lifespan in Caenorhabditis elegans.

Yang YY, Gangoiti JA, Sedensky MM, Morgan PG.

Mech Ageing Dev. 2009 Jun;130(6):370-6. doi: 10.1016/j.mad.2009.03.003. Epub 2009 Mar 25.

17.

Time before isolating cystinotic leukocytes affects reliability of cystine determination.

Fidler MC, Gangoiti JA, Schneider JA, Barshop BA.

Pediatr Nephrol. 2009 Dec;24(12):2465-6. doi: 10.1007/s00467-009-1185-y. Epub 2009 Apr 25. No abstract available.

18.

Organic anion transporter 3 contributes to the regulation of blood pressure.

Vallon V, Eraly SA, Wikoff WR, Rieg T, Kaler G, Truong DM, Ahn SY, Mahapatra NR, Mahata SK, Gangoiti JA, Wu W, Barshop BA, Siuzdak G, Nigam SK.

J Am Soc Nephrol. 2008 Sep;19(9):1732-40. doi: 10.1681/ASN.2008020180. Epub 2008 May 28.

19.

Multiple organic anion transporters contribute to net renal excretion of uric acid.

Eraly SA, Vallon V, Rieg T, Gangoiti JA, Wikoff WR, Siuzdak G, Barshop BA, Nigam SK.

Physiol Genomics. 2008 Apr 22;33(2):180-92. doi: 10.1152/physiolgenomics.00207.2007. Epub 2008 Feb 12.

20.

Metabolomics identifies perturbations in human disorders of propionate metabolism.

Wikoff WR, Gangoiti JA, Barshop BA, Siuzdak G.

Clin Chem. 2007 Dec;53(12):2169-76. Epub 2007 Oct 19.

21.

Analysis of coenzyme Q in human blood and tissues.

Barshop BA, Gangoiti JA.

Mitochondrion. 2007 Jun;7 Suppl:S89-93. Epub 2007 Apr 13.

PMID:
17485249
22.

Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion.

Fidler MC, Barshop BA, Gangoiti JA, Deutsch R, Martin M, Schneider JA, Dohil R.

Br J Clin Pharmacol. 2007 Jan;63(1):36-40.

23.

Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.

Eraly SA, Vallon V, Vaughn DA, Gangoiti JA, Richter K, Nagle M, Monte JC, Rieg T, Truong DM, Long JM, Barshop BA, Kaler G, Nigam SK.

J Biol Chem. 2006 Feb 24;281(8):5072-83. Epub 2005 Dec 14.

Supplemental Content

Loading ...
Support Center